CRISPR-Cas9 as a Trojan horse.
Molecular therapy : the journal of the American Society of Gene Therapy, 31(10): 2817-2818 PMID 37607542 DOI 10.1016/j.ymthe.2023.08.005
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.